Pharmafile Logo
Pharmafocus logo
Advanced Search

Realising outsourcing’s potential

September 20, 2010

IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …

Feature
Novo Dose diabetes iPhone app

Digital Pharma: Novo launches insulin dosing app

September 17, 2010
Medical Communications, Sales and Marketing Digital Pharma blog, Novo Nordisk, app, diabetes, iphone

Novo Nordisk has launched an iPhone app for US healthcare professionals that enables to them look up dosing guidelines for …

News

J&J to acquire Crucell for $2.3 billion

September 17, 2010
Sales and Marketing Crucell, Johnson & Johnson

Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …

News

Triple account win for M:Communications

September 17, 2010
Medical Communications Axis Shield, M:Communications, Medivir, Virgin Healthcare, medical communications

London-based communications consultancy M:Communications has won three new healthcare accounts. The new business comes from in vitro diagnostic company Axis-Shield, …

News

GSK switches to subcutaneous route for antibody

September 16, 2010
Research and Development Arzerra, Genmab, GlaxoSmithKline, ofatumumab

GlaxoSmithKline says it will switch development of a new antibody treatment to a subcutaneous injection, to make it more commercially …

News

Norgine appoints global quality director

September 16, 2010
Manufacturing and Production, Research and Development Norgine, appointment, manufacturing and production, research and development

Rosemarie Corrigan has joined European specialty pharmaceutical company Norgine as director of global quality, taking a leadership role across a …

Appointment

MSD’s Dan Heapy joins MSI

September 16, 2010
Sales and Marketing MSI, appointment, sales and marketing

The MSI Consultancy has appointed Dan Heapy as a consultant. He joins MSI from MSD, where over five years he …

Appointment

Gene therapy advance hailed for thalassemia

September 16, 2010
Research and Development Bluebird Bio, gene therapy, thalassemia

A new gene therapy for one of the most frequently inherited genetic disorders has produced promising results. The trial by …

News

Novo expands diabetes research in China

September 16, 2010
Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …

News
Blog footer

Digital Pharma: Lilly aims to be social on its Lillypad

September 16, 2010
Medical Communications Digital Pharma blog, Twitter, blog, lilly

Lilly has jumped feet first into the social media scene this week, launching a corporate blog and a Twitter account. …

News

AstraZeneca’s Brilinta delayed

September 16, 2010
Sales and Marketing Brillinta, Effient, Plavix, clopidogrel

AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …

News

Representing medium-sized pharma

September 16, 2010
Sales and Marketing European Medicines Group, UCB

UCB’s Matthew Speers is the new chairman of the European Medicines Group, which represents European-owned pharma companies in the UK. …

Feature

GSK’s leukaemia drug rejected by NICE

September 16, 2010
Sales and Marketing Arzerra, GSK, NHS, NICE

GSK’s leukaemia treatment Arzerra has been rejected by NICE, which says the drug does not represent good value for the …

News

Gilenya approved in Russia, awaits FDA decision

September 16, 2010
Sales and Marketing Cladribine, Gilena, MS

Novartis has won approval for its MS drug Gilenya in Russia but still awaits the FDA’s decision on its fate …

News

Pepscan and Tibotec sign peptides deal

September 15, 2010
Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

News

FDA warns BMS over manufacturing plant in Puerto Rico

September 15, 2010
Manufacturing and Production BMS, FDA, GMP, Puerto Rico

A plant operated by Bristol-Myers Squibb in Puerto Rico has been cited by the US Food and Drug Administration for …

News

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010
Sales and Marketing Kinapse, White paper

Feature
White paper

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Feature

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026